The Trump administration offered a mix of old and new provisions in its revised 2026 Medicare Advantage and Part D Contract Year 2026 final rule.
Much of the rule (RIN 0938-AV40) released Friday by the Centers for Medicare & Medicaid Services continues or modifies provisions first implemented by the Biden administration through the Inflation Reduction Act in 2024 and 2025.
But the rule scrapped a proposal by the Biden administration for Medicare and Medicaid to cover anti-obesity drugs for weight loss.
The final rule includes several IRA provisions that require codification, given that their program instruction authority expires at the ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.